Influence of tumor response and treatment schedule on the distribution of tumor recurrence in esophageal cancer patients treated with neoadjuvant chemoradiotherapy

Publisher： John Wiley & Sons Inc

E-ISSN： 1096-9098|116|8|1096-1102

ISSN： 0022-4790

Source： JOURNAL OF SURGICAL ONCOLOGY, Vol.116, Iss.8, 2017-12, pp. : 1096-1102

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Quantified pathologic response assessed as residual tumor burden is a predictor of recurrence‐free survival in patients with rectal cancer who undergo resection after neoadjuvant chemoradiotherapy

By  

CANCER, Vol. 119, Iss. 24, 2013-12 ,pp. : 4231-4241

John Wiley & Sons Inc

Access to resources Recommend Favorite

The prognostic value of residual nodal disease following neoadjuvant chemoradiation for esophageal cancer in patients with complete primary tumor response

By  

JOURNAL OF SURGICAL ONCOLOGY, Vol. 112, Iss. 6, 2015-11 ,pp. : 597-602

John Wiley & Sons Inc

Access to resources Recommend Favorite

High infiltration of tumor‐associated macrophages is associated with a poor response to chemotherapy and poor prognosis of patients undergoing neoadjuvant chemotherapy for esophageal cancer

By  

JOURNAL OF SURGICAL ONCOLOGY, Vol. 111, Iss. 6, 2015-05 ,pp. : 752-759

John Wiley & Sons Inc

Access to resources Recommend Favorite

A Study of Inflammation-Based Predictors of Tumor Response to Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer

By  

Oncology, Vol. 85, Iss. 1, 2013-06 ,pp. : 27-32

Karger

Access to resources Recommend Favorite

Tumor heterogeneity in esophageal cancer

By  

DISEASES OF THE ESOPHAGUS (ELECTRONIC), Vol. 28, Iss. 2, 2015-02 ,pp. : 172-179

John Wiley & Sons Inc

Access to resources Recommend Favorite